Ignite Creation Date:
2024-05-06 @ 7:28 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06025214
Status:
RECRUITING
Last Update Posted:
2023-09-06
First Post:
2023-08-29
Brief Title:
Bioequivalence Study for Fluticasone Propionate 500 mcgSalmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers
Sponsor:
Respirent Pharmaceuticals Co Ltd
Organization:
Respirent Pharmaceuticals Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-22
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-29
First Submit QC Date:
August 29 2023
Study First Post Date:
2023-09-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-29
Last Update Post Date:
2023-09-06
Last Update Post Date Type:
ACTUAL